netarsudil sold brand name rhopressa among others medication treatment united states december food drug administration fda approved ophthalmic solution lowering elevated intraocular pressure people openangle glaucoma ocular european medicines agency approved uses brand name fda considers firstinclass netarsudil contraindications apart known hypersensitivity common side effects hyperaemia increased blood flow associated redness patients conjunctiva cornea verticillata drug deposits cornea eye pain side effects occur fewer people hypersensitivity reactions occur fewer overdosing netarsudil unlikely concentrations body low generally interaction studies done european label recommends apply eye drops least five minutes eye ointments least five minutes netarsudil drugs mechanism action entirely clear inhibits enzyme rho kinase appears increase outflow aqueous humor trabecular meshwork also reduce pressure veins episcleral layer drug also inhibits norepinephrine instillation eye netarsudil cleaved esterases cornea active metabolite concentrations reached blood plasma low generally detectable judge animal models drug acts least hours elimination halflife hours drug used form salt netarsudil dimesilate white light yellow crystalline powder weak acid moderately hygroscopic freely soluble water soluble httpsenwikipediaorgwikinetarsudil